Clinical Trials Logo
  1. Home
  2. Postsurgical Pain
  3. NCT05607641

Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations

Postsurgical Pain Clinical Trial

Official title:
A Multicenter, Randomized, Open-Label, Phase II/III Clinical Trial Evaluating the Efficacy and Safety of a Fixed Combination of Ketorolac / Pitofenone / Fenpiverinium Compared to Active Control in Patients With Pain After Surgical Abdominal and Pelvic Operations

Clinical Trial Summary

Neospastil (ketorolac tromethamine / pitofenone hydrochloride / fenpiverinium bromide fixed-dose combination) in a form of solution for injections and film-coated tablets has been studied as a treatment for pain after surgical abdominal and pelvic operations. The aim of the study was to test the hypothesis that Neospastil was non-inferior (phase II) and superior (phase III) than ketorolac tromethamine monotherapy due to the additional relaxing effect of pitofenone and fenpiverinium on the smooth muscles of internal organs. The study also aimed to show that Neospastil is safe and well-tolerated in people who have pain after surgical abdominal and pelvic operations. Study treatment was initiated with parenteral form of study drug (first 24 hours) and then switched to oral formulation. This trial was conducted in accordance with the ethical principles of Good Clinical Practice and International Council for Harmonization (ICH) Harmonized Tripartite Guidelines.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05607641
Study type Interventional
Source Darnitsa Pharmaceutical Company
Contact
Status Completed
Phase Phase 2/Phase 3
Start date July 7, 2021
Completion date May 13, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT04774328 - Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair Phase 1/Phase 2
Completed NCT03731364 - Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty Phase 2
Recruiting NCT05193227 - Sustained Release Lidocaine for the Treatment of Postoperative Pain Phase 2
Completed NCT01562483 - The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain Phase 2
Completed NCT02081703 - Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery Phase 2
Recruiting NCT04647435 - Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction Phase 3
Completed NCT01582477 - TAP-patients With Robotic Assisted Lap Prostatectomy Phase 4
Suspended NCT04681027 - Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children Phase 3
Not yet recruiting NCT06202989 - Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty Phase 3
Completed NCT01731730 - Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery Phase 2
Recruiting NCT05698914 - Telehealth Mindfulness After Spine Surgery N/A
Completed NCT04203537 - Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin) Phase 1/Phase 2
Completed NCT03789318 - Study in Subjects Undergoing Complete Abdominoplasty Phase 2
Completed NCT04648683 - Postoperative Telehealth Mindfulness Intervention After Spine Surgery N/A
Completed NCT06412380 - Influence of Insertion Torque and Bone Type on Post-operative Pain N/A
Recruiting NCT05394402 - A Trial of SHR0410 Injection in Postsurgical Pain Management Phase 2
Not yet recruiting NCT06344169 - Dinalbuphine Ester (Naldebain) for Pain Management After Cesarean Section Phase 2/Phase 3